These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23716300)

  • 21. Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    Baldwin SL; Reese VA; Larsen SE; Beebe E; Guderian J; Orr MT; Fox CB; Reed SG; Coler RN
    PLoS One; 2021; 16(3):e0247990. PubMed ID: 33705411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of adjuvant formulation in the development of a tuberculosis vaccine.
    Baldwin SL; Bertholet S; Reese VA; Ching LK; Reed SG; Coler RN
    J Immunol; 2012 Mar; 188(5):2189-97. PubMed ID: 22291184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MyD88 signaling inhibits protective immunity to the gastrointestinal helminth parasite Heligmosomoides polygyrus.
    Reynolds LA; Harcus Y; Smith KA; Webb LM; Hewitson JP; Ross EA; Brown S; Uematsu S; Akira S; Gray D; Gray M; MacDonald AS; Cunningham AF; Maizels RM
    J Immunol; 2014 Sep; 193(6):2984-93. PubMed ID: 25114104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
    Embry CA; Franchi L; Nuñez G; Mitchell TC
    Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.
    Desbien AL; Dubois Cauwelaert N; Reed SJ; Bailor HR; Liang H; Carter D; Duthie MS; Fox CB; Reed SG; Orr MT
    J Immunol; 2016 Dec; 197(11):4351-4359. PubMed ID: 27794001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Cho SN; Coler RN; Reed SG; Shin SJ
    Vaccine; 2016 Apr; 34(19):2179-87. PubMed ID: 27005808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
    Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
    Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
    Bowen WS; Minns LA; Johnson DA; Mitchell TC; Hutton MM; Evans JT
    Sci Signal; 2012 Feb; 5(211):ra13. PubMed ID: 22337809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3.
    Liu G; Zhai X; Zhou H; Yang X; Zhang N; Tai G; Ni W
    Cell Immunol; 2018 Mar; 325():56-63. PubMed ID: 29452695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells.
    Yanagibashi T; Nagai Y; Watanabe Y; Ikutani M; Hirai Y; Takatsu K
    Immunol Lett; 2015 Jan; 163(1):22-31. PubMed ID: 25448706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.
    Buchholz BM; Billiar TR; Bauer AJ
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G531-8. PubMed ID: 20508155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
    Duthie MS; Coler RN; Laurance JD; Sampaio LH; Oliveira RM; Sousa AL; Stefani MM; Maeda Y; Matsuoka M; Makino M; Reed SG
    Infect Immun; 2014 Sep; 82(9):3979-85. PubMed ID: 25024362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvant.
    Lee MSJ; Natsume-Kitatani Y; Temizoz B; Fujita Y; Konishi A; Matsuda K; Igari Y; Tsukui T; Kobiyama K; Kuroda E; Onishi M; Marichal T; Ise W; Inoue T; Kurosaki T; Mizuguchi K; Akira S; Ishii KJ; Coban C
    Eur J Immunol; 2019 Sep; 49(9):1433-1440. PubMed ID: 31087643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
    Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
    Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF.
    McAleer JP; Rossi RJ; Vella AT
    J Immunol; 2009 May; 182(9):5322-30. PubMed ID: 19380779
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Kim WS; Jung ID; Kim JS; Kim HM; Kwon KW; Park YM; Shin SJ
    Front Cell Infect Microbiol; 2018; 8():95. PubMed ID: 29637049
    [No Abstract]   [Full Text] [Related]  

  • 39. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
    Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN
    Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A.
    Lambert SL; Yang CF; Liu Z; Sweetwood R; Zhao J; Cheng L; Jin H; Woo J
    PLoS One; 2012; 7(12):e51618. PubMed ID: 23284726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.